A prototype beam delivery system for the proton medical accelerator at Loma Linda. 1991

G Coutrakon, and M Bauman, and D Lesyna, and D Miller, and J Nusbaum, and J Slater, and J Johanning, and J Miranda, and P M DeLuca, and J Siebers
Loma Linda University Medical Center, California 92354.

A variable energy proton accelerator was commissioned at Fermi National Accelerator Laboratory for use in cancer treatment at the Loma Linda University Medical Center. The advantages of precise dose localization by proton therapy, while sparing nearby healthy tissue, are well documented [R. R. Wilson, Radiology 47, 487 (1946); M. Wagner, Med. Phys. 9, 749 (1982); M. Goitein and F. Chen, Med. Phys. 10, 831 (1983)]. One of the components of the proton therapy facility is a beam delivery system capable of delivering precise dose distributions to the target volume in the patient. To this end, a prototype beam delivery system was tested during the accelerator's commissioning period. The beam delivery system consisted of a beam spreading device to produce a large, uniform field, a range modulator to generate a spread out Bragg peak (SOBP), and various beam detectors to measure intensity, beam centering, and dose distributions. The beam delivery system provided a uniform proton dose distribution in a cylindrical volume of 20-cm-diam area and 9-cm depth. The dose variations throughout the target volume were found to be less than +/- 5%. Modifications in the range modulator should reduce this considerably. The central axis dose rate in the region of the SOBP was found to be 0.4 cGy/spill with an incident beam intensity of 6.7 x 10(9) protons/spill. With an accelerator repetition rate of 30 spills/min and expected intensity of 2.5 x 10(10) protons/spill for patient treatment, this system can provide 50 cGy/min for a 20-cm-diam field and 9-cm range modulation.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010315 Particle Accelerators Devices which accelerate electrically charged atomic or subatomic particles, such as electrons, protons or ions, to high velocities so they have high kinetic energy. Betatrons,Linear Accelerators,Accelerator, Linear,Accelerator, Particle,Accelerators, Linear,Accelerators, Particle,Betatron,Linear Accelerator,Particle Accelerator
D011522 Protons Stable elementary particles having the smallest known positive charge, found in the nuclei of all elements. The proton mass is less than that of a neutron. A proton is the nucleus of the light hydrogen atom, i.e., the hydrogen ion. Hydrogen Ions,Hydrogen Ion,Ion, Hydrogen,Ions, Hydrogen,Proton
D004867 Equipment Design Methods and patterns of fabricating machines and related hardware. Design, Equipment,Device Design,Medical Device Design,Design, Medical Device,Designs, Medical Device,Device Design, Medical,Device Designs, Medical,Medical Device Designs,Design, Device,Designs, Device,Designs, Equipment,Device Designs,Equipment Designs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Coutrakon, and M Bauman, and D Lesyna, and D Miller, and J Nusbaum, and J Slater, and J Johanning, and J Miranda, and P M DeLuca, and J Siebers
January 1991, Medical physics,
G Coutrakon, and M Bauman, and D Lesyna, and D Miller, and J Nusbaum, and J Slater, and J Johanning, and J Miranda, and P M DeLuca, and J Siebers
November 1994, Medical physics,
G Coutrakon, and M Bauman, and D Lesyna, and D Miller, and J Nusbaum, and J Slater, and J Johanning, and J Miranda, and P M DeLuca, and J Siebers
June 1999, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
G Coutrakon, and M Bauman, and D Lesyna, and D Miller, and J Nusbaum, and J Slater, and J Johanning, and J Miranda, and P M DeLuca, and J Siebers
September 1997, Medical physics,
G Coutrakon, and M Bauman, and D Lesyna, and D Miller, and J Nusbaum, and J Slater, and J Johanning, and J Miranda, and P M DeLuca, and J Siebers
January 1992, International journal of radiation oncology, biology, physics,
G Coutrakon, and M Bauman, and D Lesyna, and D Miller, and J Nusbaum, and J Slater, and J Johanning, and J Miranda, and P M DeLuca, and J Siebers
August 2007, Technology in cancer research & treatment,
G Coutrakon, and M Bauman, and D Lesyna, and D Miller, and J Nusbaum, and J Slater, and J Johanning, and J Miranda, and P M DeLuca, and J Siebers
July 1982, Respiratory care,
G Coutrakon, and M Bauman, and D Lesyna, and D Miller, and J Nusbaum, and J Slater, and J Johanning, and J Miranda, and P M DeLuca, and J Siebers
June 2004, International journal of radiation oncology, biology, physics,
G Coutrakon, and M Bauman, and D Lesyna, and D Miller, and J Nusbaum, and J Slater, and J Johanning, and J Miranda, and P M DeLuca, and J Siebers
January 2001, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB),
G Coutrakon, and M Bauman, and D Lesyna, and D Miller, and J Nusbaum, and J Slater, and J Johanning, and J Miranda, and P M DeLuca, and J Siebers
December 1984, CDA journal,
Copied contents to your clipboard!